What Kuehnle Agrosystems does

Kuehnle Agrosystems (KAS) is a Hawaii-based, privately held biotech company founded in 2007 that develops and produces high-value natural ingredients from microalgae for the food, feed, and health industries. Its commercial focus spans two product families: natural astaxanthin derived from Haematococcus pluvialis (sold or planned under the ASTAFUSION, OLA'ASTA, and FANTASTA ingredient brands for cosmetics, nutraceuticals, functional foods, beverages, pet foods, and aquaculture feed) and a Chlamydomonas reinhardtii-based plant protein ingredient for alternative-protein applications that holds US FDA GRAS status.

KAS's core technology is a patented dark fermentation platform that produces heterotrophic, non-GMO algal strains in standard fermentation vessels. The company holds granted patents on both the fermentation process and on the first scalable industrial manufacturing of Chlamydomonas using fermentation. Management claims the platform delivers roughly 90% production cost reduction, 10x faster cycle times (days versus weeks), and approximately one-tenth the energy, water, and land footprint of conventional photobioreactor and open-pond systems.

The business model combines B2B ingredient supply (direct sales of astaxanthin ingredients to nutraceutical, cosmetic, aquaculture, and food companies) with technology licensing (royalty-bearing licenses of its algal protein and fermentation technology to partners with production capacity) and strategic co-development partnerships — most notably a 2025 partnership with Corbion for global scale-up of natural astaxanthin. The company maintains headquarters in Honolulu, Hawaii, and an additional office in Cork, Ireland, and has raised approximately $8.8 million in equity across multiple rounds since 2010, with Aqua-Spark, S2G Investments, Cavallo Ventures, and HATCH among its investors.

Name

Kuehnle Agrosystems

Legal name

KUEHNLE AGROSYSTEMS INC

Website

https://kuehnleagro.com

Company type

Private

Founded year

2007

Operating status

Operating

Headcount range

1–10 employees

Short description

Kuehnle Agrosystems is a Hawaii-based biotech that uses patented dark fermentation of non-GMO microalgae to produce affordable natural astaxanthin (for cosmetics, nutraceuticals, aquaculture feed, and functional foods) and GRAS-status plant protein (from Chlamydomonas), selling ingredients and licensing its platform to B2B partners globally.

Ownership category

akta.pro rank

Product category

Microalgae Bioproducts

NAICS

Starch and Vegetable Fats and Oils Manufacturing (31122), Fats and Oils Refining and Blending (311225)

SIC

Food And Kindred Products (2000), Industrial Organic Chemicals (2860)

akta.pro primary industry

Algae & Seaweed Proteins (Microalgae/Spirulina, Macroalgae) (AFAJAHAF)

Keywords

• Microalgae biotechnology
• Natural astaxanthin ingredients
• Algal protein manufacturing
• Dark fermentation platform
• Aquaculture feed additives

Headquarters

HQ city

Honolulu

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Operations, Supply Chain, Marketing or Sales

Revenue model

1. Astaxanthin Ingredient Sales: Sale of natural astaxanthin products including ASTAFUSION for cosmetics, and OLA'ASTA and FANTASTA for nutraceuticals, foods, beverages, and pet foods. Targets both human and animal nutrition markets.
2. Algal Protein Licensing: Licensing of affordable algal protein technology to partners who have ambition and vision to bring the technology to market. Seeking licensing partners with production capabilities.
3. Technology Partnership Revenue: Revenue through strategic partnerships such as Corbion collaboration, combining KAS fermentation platform with partner production capabilities for market-scale delivery.

Go-to-market motion3 records

Distribution channels3 records

Marketing channels4 records

Core offering

Kuehnle AgroSystems produces high-value natural ingredients from microalgae using a patented dark fermentation platform. Its lead product is natural astaxanthin sold under the ASTAFUSION, OLA'ASTA, and FANTASTA ingredient brands for cosmetics, nutraceuticals, foods, beverages, pet foods, and aquaculture feed. A secondary offering is a highly digestible, GRAS-status plant-based protein derived from Chlamydomonas reinhardtii for alternative-protein applications.

Product overview

Kuehnle AgroSystems (KAS) is a biotech company producing high-value natural products from microalgae for food, feed, and health industries. The company's portfolio centers on two lead products: natural astaxanthin (ASTAFUSION®, OLA'ASTA®, FANTASTA®) derived from Haematococcus pluvialis microalgae, and plant-based protein from Chlamydomonas reinhardtii. Both products are manufactured using KAS's patented dark fermentation platform, which enables rapid production (days instead of weeks), 90% cost reduction, and significantly lower land, water, and energy requirements compared to traditional methods. Applications span aquaculture feeds, nutraceuticals, cosmetics/skincare, and functional foods/beverages.

Differentiator

Problem solved

Functional benefit

Brands

• ASTAFUSION: Natural astaxanthin product (INCI name Haematococcus Pluvialis Extract) for cosmetics and skincare applications.
• OLA'ASTA
• FANTASTA

Products and services

• ASTAFUSION®

Quantifiable outcome

• 6000x stronger antioxidant activity than Vitamin C, 560x stronger than Vitamin E
• +3 more outcomes

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

One partnership is on record.

• CorbioncoreStrategic or Co-development Partner · 19 August 2025Strategic partnership between Kuehnle AgroSystems and Corbion, the Amsterdam-based global leader in sustainable ingredients, to develop and commercialize high-quality natural astaxanthin derived from non-GMO heterotrophic algae. KAS contributes advanced fermentation platform and proprietary non-GMO algae strains; Corbion contributes industrial production capabilities, regulatory and go-to-market expertise. Partnership focuses on developing esterified astaxanthin for human and animal nutrition markets.

Scale indicators7 records

Recent moves7 records

Expansion highlights6 records

Emerging players

• Solazyme (now TerVia/TerraVia): Pioneer in heterotrophic microalgae fermentation for food and personal-care ingredients; historically the closest precedent for KAS's heterotrophic fermentation-based algae platform at commercial scale, though now operating under restructured ownership.
• Heliae Development: US-based algae technology company developing microalgae-based products for food, nutrition, and agriculture; comparable as an emerging algae platform company pursuing similar end-markets with overlapping strain and cultivation R&D.
• Yemoja (formerly NEXT Technologies): Israel-based microalgae startup producing sustainable astaxanthin and other high-value algal extracts for nutraceuticals and cosmetics via proprietary cultivation; an emerging player with overlapping product focus in natural astaxanthin for human nutrition.

Direct peers

• Corbion: Amsterdam-based global leader in sustainable ingredients and KAS's announced 2025 strategic partner for natural astaxanthin development and commercialization; comparable as a fermentation-scale algae ingredient producer and a key distribution channel for KAS.
• Algatechnologies: Israel-based producer of natural Haematococcus pluvialis astaxanthin (Astapure) for nutraceuticals, cosmetics and food; directly comparable product portfolio and customer base, though uses phototrophic cultivation rather than KAS's dark fermentation.
• Cyanotech Corporation: US-based microalgae company producing natural astaxanthin from Haematococcus pluvialis (BioAstin) and Spirulina; directly comparable as a photobioreactor/pond-based natural astaxanthin producer that KAS's dark-fermentation technology aims to undercut on cost.
• AstaReal (Fuji Chemical Industries): Japanese-owned producer of natural astaxanthin from Haematococcus pluvialis for human nutraceuticals; one of the leading global natural astaxanthin brands and a direct benchmark for KAS's ASTAFUSION/OLA'ASTA product positioning.

Broad incumbents

• DSM-Firmenich: Global nutrition and ingredients major with established carotenoid portfolios including astaxanthin (Panaferd-AX natural and synthetic grades) for aquaculture; broad incumbent competing across KAS's end-markets at much larger scale.
• Lonza Group: Large-scale contract fermentation and ingredient manufacturer with broad nutraceutical and microbial production capabilities; relevant as a potential alternative manufacturing/scale partner or acquirer for KAS's fermentation platform.
• BASF (Nutrition & Health): Global chemical and nutrition major with Lucantin synthetic astaxanthin for aquafeed plus broader carotenoid and vitamin ingredient lines; a broad incumbent that anchors the synthetic incumbent KAS seeks to displace in aquaculture.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds9 records

Investors8 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Kuehnle Agrosystems